Ashley Haggerty, MD
Gynecologic Oncology · Philadelphia, PANPI 1639331028
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,978 of the $7,640 with a category attached, or 78.2%. 17 manufacturers reported payments, led by AstraZeneca at 37.1% of the total.
Across 61 payments — averaging $125.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Merck$1K
- Genmab U.S., Inc.$243
- Davol Inc.$228
- Myriad Genetic Laboratories, Inc.$177
- plus $675 from 11 others
Across 9 payments — averaging $35,667 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$321K
What the payments were for
- Consulting fees$5,97878%
- Food & beverage$1,66322%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $2,834 |
| GSK | 4 | $2,003 |
| Merck | 12 | $1,480 |
| Genmab U.S., Inc. | 9 | $243 |
| Davol Inc. | 2 | $228 |
| Myriad Genetic Laboratories, Inc. | 4 | $177 |
| Johnson & Johnson(3 entities) | 3 | $171 |
| Eisai Inc. | 7 | $144 |
| Hologic Sales And Service, LLC | 3 | $144 |
| AbbVie | 3 | $50 |
| Caris MPI, Inc. | 1 | $40 |
| Medtronic | 1 | $31 |
| Intuitive Surgical | 2 | $30 |
| Dilon Technologies, Inc. | 1 | $23 |
| TELA Bio, Inc. | 1 | $14 |
| Medical Device Business Services, Inc. | 1 | $13 |
| Immunogen, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$2,740
- ZEJULA$1,950
- ARISTA$142
- XARELTO$129
- myChoice CDx$125
- CoolSeal Generator$106
How this compares
$7,640 in reported general payments places this provider in the 75th percentile of 90 gynecologic oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Philadelphia
- Emily KoPhiladelphia$78K
- Anna SmithPhiladelphia$77K
- Robert BurgerPhiladelphia$59K
- Stephanie KingPhiladelphia$17K
- Sarah KimPhiladelphia$14K
- Fiona SimpkinsPhiladelphia$11K
- Janos TanyiPhiladelphia$3K
- Lea MoukarzelPhiladelphia$3K
- Charlotte MarcusPhiladelphia$660
- Camille McCallisterPhiladelphia$466
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.